Contribution: Industrial Research Assistance Program – Contributions to Firms
Scotiaderm Inc.
$43,840.00
Development of fecal incontinence barrier cream
EF 2022-23 · 2022-12-03
Résumé
Scotiaderm Inc. will develop an advanced fecal incontinence prevention and possibly treatment system. It includes a proprietary OTC topical formulation protected by a non-medicated skin barrier film.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Port Williams|Port Williams, Nova Scotia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
739815330
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2022-12-03 | 2022-23 | $40,840.00 |
| 2 | 2022-12-03 | 2022-23 | $43,840.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The total amended value is 3,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 3 000 dollars.
Agreement End Date
2023-07-28
Agreement Number
998833
Agreement Start Date
2022-12-03
Agreement Title
Development of fecal incontinence barrier cream
Agreement Title (French)
Développement d’une crème barrière pour l’incontinence fécale
Agreement Type
Contribution
Agreement Value
$43,840.00
Amendment Date
2023-05-16
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Scotiaderm Inc. will develop an advanced fecal incontinence prevention and possibly treatment system. It includes a proprietary OTC topical formulation protected by a non-medicated skin barrier film.
Description (French)
Scotiaderm Inc. développera un système avancé de prévention et éventuellement de traitement de l’incontinence fécale. Ce système comprend une formulation topique exclusive en vente libre protégée par un film barrière cutané non médicamenteux.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Halifax
Federal Riding (French)
Halifax
Federal Riding Number
12005
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
739815330
Recipient City
Port Williams|Port Williams
Recipient Country
CA
Recipient Legal Name
Scotiaderm Inc.
Recipient Postal Code
B3J 0J2
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2022-2023-Q3-998833
